These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9854319)

  • 21. Elimination of mucosal cyathostome larvae by five daily treatments with fenbendazole.
    Duncan JL; Bairden K; Abbott EM
    Vet Rec; 1998 Mar; 142(11):268-71. PubMed ID: 9569480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial of moxidectin oral gel in horses.
    DiPietro JA; Hutchens DE; Lock TF; Walker K; Paul AJ; Shipley C; Rulli D
    Vet Parasitol; 1997 Oct; 72(2):167-77. PubMed ID: 9404843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled efficacy study of the bioequivalence of Strongid C and generic pyrantel tartrate in horses.
    Valdez RA; DiPietro JA; Paul AJ; Lock TF; Hungerford LL; Todd KS
    Vet Parasitol; 1995 Nov; 60(1-2):83-102. PubMed ID: 8644462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical tests of suspension, paste, and pellet formulations of cambendazole in the horse.
    Drudge JH; Lyons ET; Tolliver SC
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):435-9. PubMed ID: 123710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled test evaluation of the benzimidazole anthelmintic VET 220-S alone or with concomitant trichlorfon treatment against naturally acquired gastrointestinal parasites in ponies.
    Bello TR
    Am J Vet Res; 1991 Apr; 52(4):566-9. PubMed ID: 2053725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose titration of moxidectin oral gel against migrating Strongylus vulgaris and Parascaris equorum larvae in pony foals.
    Monahan CM; Chapman MR; Taylor HW; French DD; Klei TR
    Vet Parasitol; 1995 Nov; 60(1-2):103-10. PubMed ID: 8644446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical anthelmintic trials in ponies with four benzimidazoles: mebendazole, cambendazole, fenbendazole, and albendazole.
    Colglazier ML; Enzie FD; Kates KC
    J Parasitol; 1977 Aug; 63(4):724-7. PubMed ID: 886410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthelmintic activity of paste and drench formulations of oxfendazole in horses.
    Kingsbury PA; Reid JF
    Vet Rec; 1981 Oct; 109(18):404-7. PubMed ID: 6461963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled dose confirmation study of a 2% moxidectin equine gel against equine internal parasites in The Netherlands.
    Eysker M; Boersema JH; Grinwis GC; Kooyman FN; Poot J
    Vet Parasitol; 1997 Jun; 70(1-3):165-73. PubMed ID: 9195720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of the efficacy of oxfendazole against the common nematode parasites of the horse.
    Duncan JL; Reid JF
    Vet Rec; 1978 Oct; 103(15):332-4. PubMed ID: 364817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probable reason why small strongyle EPG counts are returning "early" after ivermectin treatment of horses on a farm in Central Kentucky.
    Lyons ET; Tolliver SC; Collins SS
    Parasitol Res; 2009 Feb; 104(3):569-74. PubMed ID: 18931857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and epidemiology of the major gastrointestinal parasites of horses in Perth, Western Australia.
    Dunsmore JD; Jue Sue LP
    Equine Vet J; 1985 May; 17(3):208-13. PubMed ID: 2934246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence and epidemiology of gastrointestinal parasites of horses in Victoria, Australia.
    Bucknell DG; Gasser RB; Beveridge I
    Int J Parasitol; 1995 Jun; 25(6):711-24. PubMed ID: 7657457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of the efficacy of a moxidectin gel on the establishment of cyathostominae in horses.
    Vercruysse J; Eysker M; Demeulenaere D; Smets K; Dorny P
    Vet Rec; 1998 Sep; 143(11):307-9. PubMed ID: 9789349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strongyle egg reappearance period after moxidectin treatment and its relationship with management factors in UK equine populations.
    Tzelos T; Barbeito JS; Nielsen MK; Morgan ER; Hodgkinson JE; Matthews JB
    Vet Parasitol; 2017 Apr; 237():70-76. PubMed ID: 28249767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical tests with oxibendazole against gastrointestinal parasites of ponies.
    Nawalinski T; Theodorides VJ
    Am J Vet Res; 1976 Apr; 37(4):469-71. PubMed ID: 1267243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studying the faeces for the presence of parasites in horses and ponies (author's transl)].
    Mirck MH
    Tijdschr Diergeneeskd; 1978 Oct; 103(19):991-7. PubMed ID: 567859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The activity of closantel as an equine antiparasitic agent.
    Guerrero J; Michael BF; Rohovsky MW; Campbell BP
    Vet Parasitol; 1983 Feb; 12(1):71-7. PubMed ID: 6683040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical anthelmintic trials in ponies with oxfendazole and caviphos and concomitant studies on the spontaneous elimination of small strongylids.
    Colglazier ML
    Am J Vet Res; 1979 Mar; 40(3):384-6. PubMed ID: 475090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical tests of anthelmintic activity of a paste formulation of thiabendazole in horses.
    Lyons ET; Drudge JH; Tolliver SC
    Am J Vet Res; 1976 Jun; 37(6):701-2. PubMed ID: 937790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.